MeSH tree: E02.095.465.425
The measles epidemic continues to spread in the United States, with an outbreak in the southeastern state of South Carolina growing to more than 600 cases, authorities said Tuesday.
Jan 21, 2026
0
10
Treating people who are at high risk of rheumatoid arthritis (RA) can delay the onset of the disease for several years, with benefits also continuing well after treatment has stopped.
Jan 21, 2026
0
55
When the head of the nation's largest publicly operated health plan worries about the looming federal cuts to Medicaid, it's not just her job. It's personal.
Jan 20, 2026
0
10
In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the "recipe" for the transformation. Researchers at Lund University have now created a library of the 400 ...
Jan 18, 2026
0
54
The immune system remains seriously out-of-whack—in an inflammatory state of overactivation and impaired functionality—following the international gold standard for treating people with latent tuberculosis (TB) and HIV, a ...
Jan 15, 2026
0
26
Head and neck cancer trials are frequently derailed before they can deliver answers. A new analysis suggests that the most common reasons are sponsor decisions related to safety or effectiveness and poor patient recruitment.
Jan 12, 2026
0
10
A new study maps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in the plasma cells of the bone marrow and has no cure. This large immune cell atlas, which includes ...
Jan 9, 2026
0
54
Multiple myeloma, a cancer of the bone marrow, remains difficult to treat despite modern CAR T cell therapies. In recent research, a team led by Dr. Armin Rehm presents an improved immunotherapy that recognizes two distinct ...
Jan 8, 2026
0
35
Researchers from Children's Hospital of Philadelphia (CHOP) have developed a method to help cancer immunotherapies reach otherwise "invisible" tumors by helping guide therapies to their appropriate targets. This could be ...
Jan 8, 2026
0
41
For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important type of human immune cell—known as helper T cells—from stem cells in a controlled laboratory setting.
Jan 8, 2026
0
32
